Definitive Contract HT942523C0050
- Not listed
- This is a $145,168.75 firm fixed price Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Daxor Corporation, a small disadvantaged business manufacturer, for research and development of a "Direct Blood Volume Analyzer for Improvement of Combat Casualty Care." The contract is part of the Army's SBIR program and is focused on developing medical technologies to support combat casualty care. Daxor Corporation is an innovative...
- The Department of the Army Medical Command awarded a $1,098,669.00 firm fixed price contract to Daxor Corporation, a self-certified small disadvantaged business and manufacturer of goods, for Phase II research and development under the Small Business Innovation Research (SBIR) program. The contract is for Daxor's proposal titled "Direct Blood Volume Analyzer for Improvement of Combat Casualty Care" and is intended to support the development of medical technologies related to hemorrhage...
- This is a $1,899,999.72 Firm Fixed Price purchase order awarded to Daxor Corporation, a self-certified small disadvantaged business, by the Air Force Research Laboratory (AFRL) under the Small Business Innovation Research (SBIR) Program Phase II. The contract is to develop and validate hardware and methods for the BVA-200F diagnostic, which is related to blood volume analysis. The work will be performed in Oak Ridge, Tennessee, with a period of performance ending on July 31, 2026. This...
- This is a Definitive Contract awarded by the Defense Health Agency (DHA) to Delta Development Team, Inc., a self-certified small disadvantaged business, for a SBIR Phase II medical research and development project. The contract, valued at $1,626,949.54, is set aside for total small business participation. The contract calls for the development of a maturing battlefield whole blood logistics solution, medical equipment for national security efforts, and autonomous portable refrigeration units,...
- This definitive contract from the Department of the Army Medical Command awards $398,389.64 to Delta Development Team, Inc. for the transition of a maturing battlefield whole blood logistics solution. As a self-certified small disadvantaged business, Delta Development Team will deliver medical research and development services focused on developing the referenced battlefield solution. The place of performance is Tucson, Arizona and the period of performance concludes on September 30, 2023. No...
- This is a $999,079.68 Firm Fixed Price Definitive Contract awarded by the Defense Health Agency (DHA) to TDA Research, Inc., a for-profit subchapter S corporation located in Wheat Ridge, Colorado. The contract is for Phase II of the Small Business Innovation Research (SBIR) program, with the topic being "Lightweight, Compact System for Generating Lactated Ringer's Solution". The contract is set aside for small businesses. Under this contract, TDA Research will provide research,...
- <p>This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Health Agency (DHA) to Desicorp, Inc. for the development of a thermally stable whole blood product for transfusion. The contract has a firm fixed price of $249,957.36 and a completion date of January 17, 2021. As a Phase I SBIR award, this contract is focused on the initial research and feasibility exploration of the proposed technology. The contract was set aside for small businesses.</p>
- The Department of the Army Medical Command awarded a $249,337.43 firm-fixed-price purchase order to Delta Development Team, Inc., a self-certified small disadvantaged business, for medical research and development services under the SBIR (Small Business Innovation Research) program Phase I. The contract work is focused on battlefield solutions and technologies, including projects such as the development of a maturing battlefield whole blood logistics solution, medical equipment for national...
- This contract award to Combat Medical Systems LLC, a self-certified small disadvantaged business, is for the provision of perfusion services and reanimated tissue for the Defense Health Agency (DHA), a defense agency. The firm fixed-price purchase order has a ceiling value of $87,800.00 and an ultimate completion date of September 30, 2024. The contract does not have a set-aside designation. The contract appears to be related to the DHA's medical readiness programs, as Combat Medical Systems LLC...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA), a defense agency, to Sysmex America, Inc., a U.S. subsidiary of the Japanese medical diagnostic equipment manufacturer Sysmex Corporation. The contract has a ceiling value of $42,651.52 and an ultimate completion date of June 30, 2025. The contract is set aside for small businesses and provides for the delivery of Sysmex's clinical laboratory technologies and solutions, including hematology analyzers,...
This is a $1,649,996.73 Firm Fixed Price Definitive Contract awarded by the Defense Health Agency (DHA) to Daxor Corporation, a self-certified small disadvantaged business, for a SBIR Phase II project titled "Direct Blood Volume Analyzer for Improvement of Combat Casualty Care". The contract has a period of performance from July 3, 2023 to November 2, 2025 and is a total small business set-aside. Daxor Corporation, based in Oak Ridge, Tennessee, specializes in medical instrumentation and diagnostic technologies, with a focus on blood volume analysis and medical research. This SBIR Phase II contract continues the company's work on developing advanced diagnostic tools and technologies to improve combat casualty care, building on prior SBIR Phase I research. The goal is to create innovative blood volume analysis capabilities that can enhance medical interventions and treatment strategies in military medical settings.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Change Order | $0 | 4/30/25 | |
| P00001 | Supplemental Agreement for work within scope | $550.0k | 8/6/24 | |
| Not listed | Not listed | $1.1m | 6/29/23 |